Abstract
An O-aminated naphthol AS-E was designed as a prodrug to achieve reductive activation and improved aqueous solubility. During the synthesis of this designed compound, a novel transformation from aryl triflates and ethyl acetohydroximate to oxazoles was discovered. Although the initially designed O-amino naphthol AS-E was not made successfully, the eventually synthesized O-tert-butylamino derivative was found to be biologically inactive, suggesting that reductive N-O cleavage in this compound was not facile due to unfavorable steric and electronic effects.
Keywords: CREB, ethyl acetohydroximate, naphthol AS-E, oxazole, O-amination, prodrug, reductive activation.
Letters in Organic Chemistry
Title:Synthesis and Evaluation of an O-Aminated Naphthol AS-E as a Prodrug of CREB-mediated Gene Transcription Inhibition
Volume: 10 Issue: 5
Author(s): Fuchun Xie, Bingbing X. Li and Xiangshu Xiao
Affiliation:
Keywords: CREB, ethyl acetohydroximate, naphthol AS-E, oxazole, O-amination, prodrug, reductive activation.
Abstract: An O-aminated naphthol AS-E was designed as a prodrug to achieve reductive activation and improved aqueous solubility. During the synthesis of this designed compound, a novel transformation from aryl triflates and ethyl acetohydroximate to oxazoles was discovered. Although the initially designed O-amino naphthol AS-E was not made successfully, the eventually synthesized O-tert-butylamino derivative was found to be biologically inactive, suggesting that reductive N-O cleavage in this compound was not facile due to unfavorable steric and electronic effects.
Export Options
About this article
Cite this article as:
Xie Fuchun, Li Bingbing X. and Xiao Xiangshu, Synthesis and Evaluation of an O-Aminated Naphthol AS-E as a Prodrug of CREB-mediated Gene Transcription Inhibition, Letters in Organic Chemistry 2013; 10 (5) . https://dx.doi.org/10.2174/1570178611310050014
DOI https://dx.doi.org/10.2174/1570178611310050014 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transcription Factors: Molecular Targets for Prostate Cancer Intervention by Phytochemicals
Current Cancer Drug Targets Meet Our Editorial Board Member
Current Cancer Drug Targets Discovery of Novel HDAC Inhibitors by Structure-based Optimization of Cinnamic Hydroxamic Scaffold
Letters in Drug Design & Discovery Recent Progress of Novel Steroid Derivatives and Their Potential Biological Properties
Mini-Reviews in Medicinal Chemistry Patent Selections
Recent Patents on Biotechnology Monitoring Therapy with Gene Expression Profiling Reveals Physiological Differences in Drug Action
Current Pharmaceutical Design Pharmacogenetic Syndrome of Dihydropyrimidine Dehydrogenase Deficiency
Current Pharmacogenomics Oncogenic Role of SET/I2PP2A for Gynecologic Cancers
Current Drug Targets Recent Clinical Experience with Oncolytic Viruses
Current Pharmaceutical Biotechnology The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
Current Medicinal Chemistry Flexible Bronchoscopy: Importance of Standardization of Practice for the Best Route of Insertion.
Current Respiratory Medicine Reviews Integrative Exome Sequencing Analysis in Castration-Resistant Prostate Cancer in Chinese Population
Current Pharmaceutical Biotechnology Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature
Recent Patents on Anti-Cancer Drug Discovery Chitosan Nanoparticles as a Carrier for Indigofera intricata Plant Extract: Preparation, Characterization and Anticancer Activity
Current Cancer Therapy Reviews Molecular Imaging of Apoptosis for Early Prediction of Therapy Efficiency
Current Pharmaceutical Design Lanthanide Bearing Microparticulate Systems for Multi-Modality Imaging and Targeted Therapy of Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Cannabinoids
Current Drug Targets - CNS & Neurological Disorders MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers
Current Pharmaceutical Design The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Hormone-Biological Therapy in Breast Cancer: Preclinical Evidence,Clinical Studies and Future Directions
Current Cancer Drug Targets